Login / Signup

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review.

Philippe RochigneuxJeanne Thomassin-PianaSophy LaibeSerge BrunelleNaji SalemBernard EscudierGilles VassalGwenaelle Gravis
Published in: BMC cancer (2018)
In metastatic pRCC with a MET amplification, crizotinib maybe a potential met-inhibitory therapeutic option.
Keyphrases
  • tyrosine kinase
  • squamous cell carcinoma
  • small cell lung cancer
  • nucleic acid
  • advanced non small cell lung cancer
  • epidermal growth factor receptor
  • risk assessment
  • human health
  • clear cell